Risk factors

Revolution Medicines (RVMD) risk factors

Item 1A of every Revolution Medicines, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open RVMD in Gloom →
Revolution Medicines' chart, financials and news, free in your browser.Open RVMD in Gloom →
  • FY2025 10-K risk factors
    97 risks8 new8 dropped22 reworded

    Royalty Pharma financing adds debt covenants, collateral restrictions, and repayment risks to Revolution Medicines’ funding profile.

    Filed Feb 25, 2026
  • FY2024 10-K risk factors
    97 risks

    Revolution Medicines has never generated revenue from product sales and anticipates ongoing operational losses as it advances targeted RAS(ON) cancer inhibitors.

    Filed Feb 26, 2025